{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T04:05:09Z","timestamp":1788840309727,"version":"build-2803163510"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["114-2124-M-006-007"],"award-info":[{"award-number":["114-2124-M-006-007"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["113-2314-B-006-038-MY3"],"award-info":[{"award-number":["113-2314-B-006-038-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004844","name":"National Cheng Kung University Hospital","doi-asserted-by":"publisher","award":["11410012"],"award-info":[{"award-number":["11410012"]}],"id":[{"id":"10.13039\/501100004844","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Pancreatic cancer is a fatal cancer with poor prognosis and survival rate, often diagnosed usually in the advanced stage of disease. The conventional methods are usually considered for surgery or chemotherapy, and neo-adjuvant therapies have improved the survival rate in the patients. Folic acid plays a crucial role in the synthesis, metabolism, and repair of DNA; thereby, it is considered one of the biomolecules for cancer-targeted therapy for highly expressed receptors to overcome poor vasculature and dense tumor stroma, as in pancreatic cancer. This study strategizes for improving the therapeutic efficacy of pancreatic cancer via folate receptor-guided nanoparticles. The conjugation of folic acid (FA) to the LiYF\n                    <jats:sub>4<\/jats:sub>\n                    :Ce\n                    <jats:sup>3+<\/jats:sup>\n                    nanoparticles (SCNP-FA) with the photocleavage chemical molecule; firstly enters the cells through receptor-mediated endocytosis and then, releases FA intracellularly upon the trigger of radiation in a controlled manner. This nano-based approach induces ferroptosis to provoke immunogenic cell death (ICD) with higher generation of reactive oxygen species (ROS) and accumulation of lipid peroxides. It shows an abundant damage to the mitochondria and a decrease in mitochondrial membrane potential (MMP) upon treatment. This targeted therapy remodels the immunosuppressive tumor microenvironment and releases damage-associated molecular patterns (DAMPs) to initiate an immune response. These findings reveal the anti-tumor response with folate receptor-guided nanoparticles in pancreatic cancer.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1186\/s12951-025-03657-8","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T04:47:08Z","timestamp":1754974028000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Radiocleavable rare-earth nanoactivators targeting over-expressed folate receptors induce mitochondrial dysfunction and remodel immune suppressive microenvironment in pancreatic cancer"],"prefix":"10.1186","volume":"23","author":[{"given":"Tanvi","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang-Rung","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Chan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Forn-Chia","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Shen","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Sheng","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Pin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"issue":"2","key":"3657_CR1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4240\/wjgs.v15.i2.121","volume":"15","author":"D Caputo","year":"2023","unstructured":"Caputo D. Hot topics in pancreatic cancer management. World J Gastrointest Surg. 2023;15(2):121.","journal-title":"World J Gastrointest Surg"},{"key":"3657_CR2","doi-asserted-by":"crossref","unstructured":"Siegel RL, Kimberly D, Miller. Nikita Sandeep Wagle, and Ahmedin Jemal. Cancer statistics, 2023. CA: a cancer journal for clinicians 73, no. 1 (2023).","DOI":"10.3322\/caac.21763"},{"key":"3657_CR3","doi-asserted-by":"crossref","unstructured":"Sarfaty E, Khajoueinejad N, Zewde MG, Yu Allen T, Noah A. Cohen. Surgical management of pancreatic ductal adenocarcinoma: a narrative review. Translational Gastroenterol Hepatol 2023;8:23-27.","DOI":"10.21037\/tgh-23-27"},{"issue":"no. 10","key":"3657_CR4","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s00595-020-02028-0","volume":"50","author":"RJ Torphy","year":"2020","unstructured":"Torphy RJ, Fujiwara Y, Schulick Richard D. Pancreatic cancer treatment: better, but a long way to go. Surg Today. 2020;50(10):1117\u201325.","journal-title":"Surg Today"},{"key":"3657_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12964-020-0530-4","volume":"18","author":"R Baghban","year":"2020","unstructured":"Baghban R, Roshangar L, Jahanban-Esfahlan R, Seidi K, Ebrahimi-Kalan A, Jaymand M, Kolahian S, javaheri Tahereh, zare Peyman. Tumor microenvironment complexity and therapeutic implications at a glance. Cell Commun Signal. 2020;18:1\u201319.","journal-title":"Cell Commun Signal"},{"issue":"10242","key":"3657_CR6","first-page":"2008","volume":"395","author":"JD Mizrahi","year":"2020","unstructured":"Mizrahi JD, Surana R, Valle JW, Rachna T. Shroff Pancreat Cancer the Lancet. 2020;395(10242):2008\u201320.","journal-title":"Shroff Pancreat Cancer the Lancet"},{"issue":"7","key":"3657_CR7","doi-asserted-by":"crossref","first-page":"5028","DOI":"10.1002\/jcb.26663","volume":"119","author":"S Upadhyay","year":"2018","unstructured":"Upadhyay S, Sharma N, Gupta KB, Dhiman M. Role of immune system in tumor progression and carcinogenesis. J Cell Biochem. 2018;119(7):5028\u201342.","journal-title":"J Cell Biochem"},{"issue":"6","key":"3657_CR8","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s42247-021-00335-x","volume":"5","author":"V Chandrakala","year":"2022","unstructured":"Chandrakala V, Aruna V, Angajala G. Review on metal nanoparticles as nanocarriers: current challenges and perspectives in drug delivery systems. Emergent Mater. 2022;5(6):1593\u2013615.","journal-title":"Emergent Mater"},{"issue":"13","key":"3657_CR9","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.2217\/nnm-2018-0007","volume":"13","author":"H Li","year":"2018","unstructured":"Li H, Jin H, Wan W, Wu C, Wei L. Cancer nanomedicine: mechanisms, obstacles and strategies. Nanomedicine. 2018;13(13):1639\u201356.","journal-title":"Nanomedicine"},{"issue":"8","key":"3657_CR10","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.1021\/acs.nanolett.9b01735","volume":"19","author":"Q Wu","year":"2019","unstructured":"Wu Q, Xia N, Tan DLL, Rao W, Yu J, Fu C, et al. Dual-functional supernanoparticles with microwave dynamic therapy and microwave thermal therapy. Nano Lett. 2019;19(8):5277\u201386.","journal-title":"Nano Lett"},{"issue":"3","key":"3657_CR11","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1258\/0007142991902646","volume":"55","author":"SJ Duthie","year":"1999","unstructured":"Duthie SJ. Folic acid deficiency and cancer: mechanisms of DNA instability. Br Med Bull. 1999;55(3):578\u201392.","journal-title":"Br Med Bull"},{"issue":"2","key":"3657_CR12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.mehy.2011.10.023","volume":"78","author":"PH Hwang","year":"2012","unstructured":"Hwang PH, Lian L, Zavras Athanasios I. Alcohol intake and folate antagonism via CYP2E1 and ALDH1: effects on oral carcinogenesis. Med Hypotheses. 2012;78(2):197\u2013202.","journal-title":"Med Hypotheses"},{"issue":"2","key":"3657_CR13","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3945\/jn.110.131235","volume":"141","author":"TI Ibiebele","year":"2011","unstructured":"Ibiebele TI, Hughes MC, Pandeya N, Zhao Z, Montgomery G, Hayward N, Green AC, Whiteman DC, Webb Penelope M. High intake of folate from food sources is associated with reduced risk of esophageal cancer in an Australian population. J Nutr. 2011;141(2):274\u201383.","journal-title":"J Nutr"},{"key":"3657_CR14","first-page":"373","volume":"24","author":"E Cho","year":"2013","unstructured":"Cho E, Giovannucci EL, Hee-Kyung J. Nutrients related to one-carbon metabolism and risk of renal cell cancer. Cancer Causes Control. 2013;24:373\u201382.","journal-title":"Cancer Causes Control"},{"issue":"2","key":"3657_CR15","first-page":"83","volume":"64","author":"E Ward","year":"2014","unstructured":"Ward E, DeSantis C, Robbins A, Kohler Betsy, Jemal Ahmedin. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):83\u2013103.","journal-title":"CA Cancer J Clin"},{"key":"3657_CR16","doi-asserted-by":"crossref","unstructured":"Williams JD, Elaine L, Jacobson H, Kim M, Kim. and M. K. Jacobson. Folate in skin cancer prevention. Water Soluble Vitamins: Clin Res Future Application 2012;56:181\u2013 197.","DOI":"10.1007\/978-94-007-2199-9_10"},{"issue":"7","key":"3657_CR17","doi-asserted-by":"crossref","first-page":"517","DOI":"10.7326\/0003-4819-129-7-199810010-00002","volume":"129","author":"E Giovannucci","year":"1998","unstructured":"Giovannucci E, Stampfer MJ, Colditz GA, Hunter DJ, Fuchs C, Rosner BA, Speizer FE. Willett. Multivitamin use, folate, and colon cancer in women in the nurses\u2019 health study. Ann Intern Med. 1998;129(7):517\u201324.","journal-title":"Ann Intern Med"},{"issue":"9","key":"3657_CR18","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1038\/bjc.2014.155","volume":"110","author":"P Chen","year":"2014","unstructured":"Chen P, Li C, Li X, Li J, Chu R, Wang H. Higher dietary folate intake reduces the breast cancer risk: a systematic review and meta-analysis. Br J Cancer. 2014;110(9):2327\u201338.","journal-title":"Br J Cancer"},{"issue":"9","key":"3657_CR19","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1002\/ijc.24723","volume":"126","author":"J Kotsopoulos","year":"2010","unstructured":"Kotsopoulos J, Hecht JL, Marotti JD, Kelemen LE, Shelley S. Tworoger. Relationship between dietary and supplemental intake of folate, methionine, vitamin B6 and folate receptor \u03b1 expression in ovarian tumors. Int J Cancer. 2010;126(9):2191\u20138.","journal-title":"Int J Cancer"},{"issue":"1","key":"3657_CR20","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14010014","volume":"14","author":"C Mart\u00edn-Sabroso","year":"2021","unstructured":"Mart\u00edn-Sabroso C, Torres-Su\u00e1rez AI, Alonso-Gonz\u00e1lez Mario, Fern\u00e1ndez-Carballido Ana, Fraguas-S\u00e1nchez Ana Isabel. Active targeted nanoformulations via folate receptors: state of the art and future perspectives. Pharmaceutics. 2021;14(1): 14.","journal-title":"Pharmaceutics"},{"issue":"1","key":"3657_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/pterid-2014-0013","volume":"26","author":"M Bartouskova","year":"2015","unstructured":"Bartouskova M, Melichar B, Mohelnikova-Duchonova B. Folate receptor: a potential target in ovarian cancer. Pteridines. 2015;26(1):1\u201312.","journal-title":"Pteridines"},{"issue":"1","key":"3657_CR22","doi-asserted-by":"crossref","DOI":"10.1177\/03000605231223064","volume":"52","author":"RH Thabet","year":"2024","unstructured":"Thabet RH, alessa Raneem Eid Mustafa, Al-Smadi Zahraa Khaldoon Khaleel, alshatnawi Banah Saleh Gabr, amayreh Batool Mahmoud Ibrahim, Al-Dwaaghreh Renad Bilal Ahmad, salah Sereen Khalid Ahmad. Folic acid: friend or foe in cancer therapy. J Int Med Res. 2024;52(1): 03000605231223064.","journal-title":"J Int Med Res"},{"issue":"1","key":"3657_CR23","volume":"7","author":"F Peng","year":"2022","unstructured":"Peng F, Liao M, Qin R, Zhu S, Peng C, Fu L, Chen Y, Han B. Regulated cell death (RCD) in cancer: key pathways and targeted therapies. Signal Transduct Target Ther. 2022;7(1): 286.","journal-title":"Signal Transduct Target Ther"},{"key":"3657_CR24","volume":"105","author":"R Zhou","year":"2023","unstructured":"Zhou R, Zhou LQL, Geng R, Yang S, Wu J. P4HA1 activates HMGCS1 to promote nasopharyngeal carcinoma ferroptosis resistance and progression. Cell Signal. 2023;105: 110609.","journal-title":"Cell Signal"},{"key":"3657_CR25","first-page":"322","volume":"24","author":"H Zhou","year":"2023","unstructured":"Zhou H, Liu Z, Zhang Z, Pandey NK, Amador E, Nguyen W, Chudal L, Xiong L, Chen W, Wen Y. Copper-cysteamine nanoparticle-mediated microwave dynamic therapy improves cancer treatment with induction of ferroptosis. Bioact Mater. 2023;24:322\u201330.","journal-title":"Bioact Mater"},{"issue":"45","key":"3657_CR26","volume":"19","author":"H Lei","year":"2023","unstructured":"Lei H, Li Q, Pei Z, Liu L, Yang N, Cheng L. Nonferrous ferroptosis inducer manganese molybdate nanoparticles to enhance tumor immunotherapy. Small. 2023;19(45): 2303438.","journal-title":"Small"},{"issue":"4","key":"3657_CR27","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ccell.2024.03.011","volume":"42","author":"G Lei","year":"2024","unstructured":"Lei G, Li Zhuang, and, Gan B. The roles of ferroptosis in cancer: tumor suppression, tumor microenvironment, and therapeutic interventions. Cancer Cell. 2024;42(4):513\u201334.","journal-title":"Cancer Cell"},{"issue":"5","key":"3657_CR28","doi-asserted-by":"crossref","first-page":"9084","DOI":"10.1021\/acsnano.1c02283","volume":"15","author":"D Manoharan","year":"2021","unstructured":"Manoharan D, Chang L-C, Wang L-C, Shan Y-S, Lin F-C, Wu L-C, Sheu H-S, Su W-P. Synchronization of nanoparticle sensitization and radiosensitizing chemotherapy through cell cycle arrest achieving ultralow x-ray dose delivery to pancreatic tumors. ACS Nano. 2021;15(5):9084\u2013100.","journal-title":"ACS Nano"},{"issue":"44","key":"3657_CR29","volume":"16","author":"K Keevend","year":"2020","unstructured":"Keevend K, Krummenacher R, Kungas E, Gerken LR, Gogos A, Stiefel M, Herrmann IK. Correlative cathodoluminescence electron microscopy: immunolabeling using rare-earth element doped nanoparticles. Small. 2020;16(44): 2004615.","journal-title":"Small"},{"key":"3657_CR30","doi-asserted-by":"crossref","unstructured":"Celikbas, E., Saymaz, A., Gunduz, H., Koc, I., Cakir, E., Sennaroglu, A., \u2026 Onbasli,K. (2023). Image-guided enhanced PDT\/PTT combination therapy using brominated hemicyanine-loaded folate receptor-targeting Ag2S quantum dots. Bioconjugate Chemistry, 34(5), 880\u2013892.","DOI":"10.1021\/acs.bioconjchem.3c00096"},{"issue":"5","key":"3657_CR31","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41422-019-0164-5","volume":"29","author":"D Tang","year":"2019","unstructured":"Tang D, Kang R, Berghe TV, Vandenabeele P, Guido Kroemer. The molecular machinery of regulated cell death. Cell Res. 2019;29(5):347\u201364.","journal-title":"Cell Res"},{"key":"3657_CR32","doi-asserted-by":"crossref","first-page":"637162","DOI":"10.3389\/fcell.2021.637162","volume":"9","author":"PB Chen, Xin","year":"2021","unstructured":"Chen, Xin PB, Comish D, Tang. Characteristics and biomarkers of ferroptosis. Front Cell Dev Biology. 2021;9:637162.","journal-title":"Front Cell Dev Biology"},{"issue":"2","key":"3657_CR33","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","volume":"31","author":"D Tang","year":"2021","unstructured":"Tang D, Chen X, Kang R, Kroemer G. Ferroptosis: molecular mechanisms and health implications. Cell Res. 2021;31(2):107\u201325.","journal-title":"Cell Res"},{"issue":"1","key":"3657_CR34","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41420-024-01825-7","volume":"10","author":"X Jin","year":"2024","unstructured":"Jin X, Tang J, Qiu X, Nie X, Ou S, Wu G, Zhang R, Zhu J. Ferroptosis: emerging mechanisms, biological function, and therapeutic potential in cancer and inflammation. Cell Death Discov. 2024;10(1):45.","journal-title":"Cell Death Discov"},{"key":"3657_CR35","volume":"725","author":"L Liu","year":"2022","unstructured":"Liu L, Zhang C, Qu S, Liu R, Chen H, Liang Z, Tian Z, Li L, Ma S, Liu X. ESR1 inhibits ionizing radiation-induced ferroptosis in breast cancer cells via the NEDD4L\/CD71 pathway. Arch Biochem Biophys. 2022;725: 109299.","journal-title":"Arch Biochem Biophys"},{"key":"3657_CR36","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.586578","volume":"8","author":"F Kuang","year":"2020","unstructured":"Kuang F, Liu J, Tang D, Kang R. Oxidative damage and antioxidant defense in ferroptosis. Front Cell Dev Biol. 2020;8: 586578.","journal-title":"Front Cell Dev Biol"},{"key":"3657_CR37","doi-asserted-by":"crossref","unstructured":"Chen D, Eyupoglu IY. and Nicolai Savaskan. Ferroptosis and cell death analysis by flow cytometry. Cell Viability Assays: Methods Protocols 2017;1601:71\u201377.","DOI":"10.1007\/978-1-4939-6960-9_6"},{"issue":"8","key":"3657_CR38","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41419-023-06045-y","volume":"14","author":"Yu\u2019E Liu","year":"2023","unstructured":"Liu Yu\u2019E, Lu S, Wu Lei-lei, Yang L, Yang L, Wang J. The diversified role of mitochondria in ferroptosis in cancer. Cell Death Dis. 2023;14(8):519.","journal-title":"Cell Death Dis"},{"key":"3657_CR39","doi-asserted-by":"crossref","unstructured":"Battaglia A, Martina A, Sacco E, Vecchio S, Scicchitano L, Petriaggi E, Giorgio S, Bulotta et al. Iron affects the sphere-forming ability of ovarian cancer cells in non-adherent culture conditions. Front Cell Dev Biology 2023;14(11):1272667.","DOI":"10.3389\/fcell.2023.1272667"},{"key":"3657_CR40","doi-asserted-by":"crossref","unstructured":"Dodson M, Castro-Portuguez R, Donna D, Zhang. NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox biology 23 (2019): 101107.","DOI":"10.1016\/j.redox.2019.101107"},{"issue":"21","key":"3657_CR41","volume":"30","author":"P Wang","year":"2020","unstructured":"Wang P, Liu S, Hu M, Zhang H, Duan D, He J, Hong J, et al. Peroxidase-like nanozymes induce a novel form of cell death and inhibit tumor growth in vivo. Adv Funct Mater. 2020;30(21): 2000647.","journal-title":"Adv Funct Mater"},{"issue":"11","key":"3657_CR42","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41580-020-0270-8","volume":"21","author":"S Bedoui","year":"2020","unstructured":"Bedoui S, Herold MJ, Strasser A. Emerging connectivity of programmed cell death pathways and its physiological implications. Nat Rev Mol Cell Biol. 2020;21(11):678\u201395.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3657_CR43","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejphar.2017.02.015","volume":"799","author":"J Khamseekaew","year":"2017","unstructured":"Khamseekaew J, Kumfu S, Wongjaikam S, Kerdphoo S, Jaiwongkam T, Srichairatanakool S, Fucharoen S, Chattipakorn SC, Chattipakorn Nipon. Effects of iron overload, an iron chelator and a T-type calcium channel blocker on cardiac mitochondrial biogenesis and mitochondrial dynamics in thalassemic mice. Eur J Pharmacol. 2017;799:118\u201327.","journal-title":"Eur J Pharmacol"},{"issue":"10","key":"3657_CR44","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/cac2.12487","volume":"43","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, Sun L, Guo J, Ma J. The crosstalk between ferroptosis and anti-tumor immunity in the tumor microenvironment: molecular mechanisms and therapeutic controversy. Cancer Commun. 2023;43(10):1071\u201396.","journal-title":"Cancer Commun"},{"issue":"1","key":"3657_CR45","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/imr.12574","volume":"280","author":"AD Garg","year":"2017","unstructured":"Garg AD, Agostinis Patrizia. Cell deathimmunity in cancer: from danger signals to mimicry of pathogen defense responses. Immunol Rev. 2017;280(1):126\u201348.","journal-title":"Immunol Rev"},{"key":"3657_CR46","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001369","volume":"8","author":"I Efimova","year":"2020","unstructured":"Efimova I, Catanzaro E, Van der Meeren L, Turubanova VD, Hammad H, Mishchenko TA, Vedunova MV, et al. Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity. J Immunother Cancer. 2020;8: 2.","journal-title":"J Immunother Cancer"},{"key":"3657_CR47","doi-asserted-by":"crossref","unstructured":"Yu B, Choi B, Li W, Dong-Hyun K. Magnetic field boosted ferroptosis-like cell death and responsive MRI using hybrid vesicles for cancer immunotherapy. Nature communications 11, no. 1 (2020): 3637.","DOI":"10.1038\/s41467-020-17380-5"},{"issue":"3","key":"3657_CR48","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/odi.14077","volume":"29","author":"Y-Y Zhao","year":"2023","unstructured":"Zhao Y-Y, Lian Jun\u2010Xiang, Lan Z, Zou Ke\u2010Long, wang Wei\u2010Ming, yu Guang\u2010Tao. Ferroptosis promotes anti\u2010tumor immune response by inducing immunogenic exposure in HNSCC. Oral Dis. 2023;29(3):933\u201341.","journal-title":"Oral Dis"},{"key":"3657_CR49","doi-asserted-by":"crossref","unstructured":"Stockwell, B. R., Angeli, J. P. F., Bayir, H., Bush, A. I., Conrad, M., Dixon, S.J., \u2026 Zhang, D. D. (2017). Ferroptosis: a regulated cell death nexus linking metabolism,redox biology, and disease. Cell, 171(2), 273\u2013285.","DOI":"10.1016\/j.cell.2017.09.021"},{"issue":"10","key":"3657_CR50","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nrc.2016.81","volume":"16","author":"M Yang","year":"2016","unstructured":"Yang M, Vousden KH. Serine and one-carbon metabolism in cancer. Nat Rev Cancer. 2016;16(10):650\u201362.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"3657_CR51","volume":"9","author":"M Haripriyaa","year":"2023","unstructured":"Haripriyaa M, Suthindhiran K. Pharmacokinetics of nanoparticles: current knowledge, future directions and its implications in drug delivery. Future J Pharm Sci. 2023;9(1): 113.","journal-title":"Future J Pharm Sci"},{"key":"3657_CR52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-020-01284-5","volume":"20","author":"E Dai","year":"2021","unstructured":"Dai E, Zhu Z, Wahed S, Qu Z. Storkus, and Zong Sheng guo. Epigenetic modulation of antitumor immunity for improved cancer immunotherapy. Mol Cancer. 2021;20:1\u201327.","journal-title":"Mol Cancer"},{"issue":"1","key":"3657_CR53","volume":"9","author":"Q Zhou","year":"2024","unstructured":"Zhou Q, Meng Y, Li D, Yao L, Le J, Liu Y, Sun Y, Zeng F, chen Xiang, deng Guangtong. Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies. Signal Transduct Target Ther. 2024;9(1): 55.","journal-title":"Signal Transduct Target Ther"},{"key":"3657_CR54","doi-asserted-by":"crossref","unstructured":"Zhang, L., Wang, Y., Karges, J., Tang, D., Zhang, H., Zou, K., \u2026 Xiao, H. (2023).Tetrahedral DNA Nanostructure with Interferon Stimulatory DNA Delivers Highly Potent Toxins and Activates the cGAS-STING Pathway for Robust Chemotherapy and Immunotherapy. Advanced Materials, 35(8), 2210267.","DOI":"10.1002\/adma.202210267"},{"issue":"7755","key":"3657_CR55","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","volume":"569","author":"W Wang","year":"2019","unstructured":"Wang W, Green M, Choi JE, Gij\u00f3n M, Kennedy PD, Johnson JK, Liao P, et al. CD8\u2009+\u2009T cells regulate tumour ferroptosis during cancer immunotherapy. Nature. 2019;569(7755):270\u20134.","journal-title":"Nature"},{"issue":"21","key":"3657_CR56","volume":"36","author":"B Wang","year":"2024","unstructured":"Wang B, Zhou J, Li R, Tang D, Cao Z, Xu C, Xiao H. Activating CD8\u2009+\u2009T cells by Pt (IV) prodrug-based nanomedicine and aPD\u2010L1 antibody for enhanced cancer immunotherapy. Adv Mater. 2024;36(21): 2311640.","journal-title":"Adv Mater"},{"key":"3657_CR57","doi-asserted-by":"crossref","unstructured":"Shen, M., Wang, Y., Zhang, L., Bing, T., Li, X., Zhu, L., \u2026 Yu, Y. (2025). Ultrasound-Triggered Cascade Delivery via Poly\u2010Oxaliplatin Nanoparticles for Immunotherapy. Advanced Functional Materials, 2425565.","DOI":"10.1002\/adfm.202425565"},{"issue":"15","key":"3657_CR58","doi-asserted-by":"crossref","first-page":"6471","DOI":"10.1021\/acs.nanolett.1c01401","volume":"21","author":"Z Gu","year":"2021","unstructured":"Gu Z, Liu T, Liu C, Yang Y, Tang J, Song H, Wang Y, Yang Y, Yu Chengzhong. Ferroptosis-strengthened metabolic and inflammatory regulation of tumor-associated macrophages provokes potent tumoricidal activities. Nano Lett. 2021;21(15):6471\u20139.","journal-title":"Nano Lett"},{"key":"3657_CR59","volume":"10","author":"Z Shi","year":"2022","unstructured":"Shi Z, Zheng J, Tang W, Bai Y, Zhang L, Xuan Z, sun Huimin, shao Chen. Multifunctional nanomaterials for ferroptotic cancer therapy. Front Chem. 2022;10: 868630.","journal-title":"Front Chem"},{"issue":"28","key":"3657_CR60","doi-asserted-by":"crossref","first-page":"2301561","DOI":"10.1002\/adhm.202301561","volume":"12","author":"L-G Li","year":"2023","unstructured":"Li L-G, Yang Xiao\u2010Xin, Xu Hua\u2010Zhen, Yu Ting\u2010Ting, Qi\u2010Rui Li J, Xing\u2010Chun H. A dihydroartemisinin\u2010loaded nanoreactor motivates anti\u2010cancer immunotherapy by synergy\u2010induced ferroptosis to activate cgas\/sting for reprogramming of macrophage. Adv Healthc Mater. 2023;12(28):2301561.","journal-title":"Adv Healthc Mater"},{"key":"3657_CR61","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jconrel.2022.06.048","volume":"349","author":"N Kaeokhamloed","year":"2022","unstructured":"Kaeokhamloed N, Legeay S, Roger E. FRET as the tool for in vivo nanomedicine tracking. J Controlled Release. 2022;349:156\u201373.","journal-title":"J Controlled Release"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03657-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03657-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03657-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T18:03:08Z","timestamp":1767463388000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-025-03657-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3657"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03657-8","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,12]]},"assertion":[{"value":"12 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised:  the affiliations have been updated.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"562"}}